Replies to post #101452 on Ayala Pharmaceuticals Inc (ADXS)

[raja48185]

I'm saying Petit is making moves and left Advaxis right before the share price dropped 95%+. I say good for him.

Seems as if Petit who joined Carisma Therapeutics on June 3, 2019, is not with that company anymore. I remember seeing his pic and profile on the company website; not any more. May be he did all the expert work in record time and is ready to move on. This is what he had to say on being appointed.

"I am excited to join the Carisma team and contribute toward realizing the tremendous potential of the CAR-macrophage technology, starting with the lead program in Her-2 overexpressing solid tumors and evolving the technology broadly toward building a pipeline of assets, each harnessing the unique biology of macrophages to extend the effects of engineered cell therapy through presentation of additional tumor antigen targets to the patient's immune system," said Dr. Petit. "Immunologically, I see great promise in engaging the patient's innate and adaptive immune system to supplement and extend the direct killing activity of engineered macrophages to address complex diseases."


https://www.prnewswire.com/news-releases/carisma-therapeutics-names-dr-robert-petit-as-chief-scientific-officer-300860107.html

Now after joining OST, he says this

https://www.businesswire.com/news/home/20190918005918/en/

"I am excited to join the OS Therapies team and contribute toward realizing the potential of the OS Therapies lead program in the treatment of osteosarcoma,” said Dr. Petit. “I also look forward to furthering the mission of OS Therapies by assisting in building a pipeline of assets that will improve treatment options and outcomes for patients with osteosarcoma.”